To this end, we first performed chromatin immunoprecipitation and found that TCF7L2 was significantly enriched in the SPARC promoter region (−175 to −25 nt relative to the TIS) in several melanoma cell lines tested (Figure 5I), whereas LEF1 was not (see also the Supplementary Figure S2). The gene discussed is LEF1; the disease is melanoma.